VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ITIC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ITICInvestors Title Company
$276.75$523M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksITICQuarterly Financials

Investors Title Company (ITIC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Investors Title Company (ITIC) quarterly income statement — complete revenue, gross profit & net income history

ITIC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue64.01M69.52M73.02M73.65M56.56M70.63M68.83M65.38M53.46M53.68M61.41M58.31M51.34M65.49M78M70.9M69M91.04M81.42M84.96M
Revenue Growth %13.17%-1.57%6.09%12.64%5.81%31.56%12.08%12.12%4.12%-18.03%-21.27%-17.75%-25.59%-28.06%-4.2%-16.55%-4.27%18.04%20.38%37.59%
Medical Costs & Claims472K995K1.21M025.18M1.05M027.45M20.78M20.5M25.64M21.59M20.39M25.21M35.44M35.14M30.03M41.02M39.56M35.78M
Medical Cost Ratio %0.74%1.43%1.66%0%44.52%1.48%0%41.99%38.87%38.19%41.76%37.03%39.72%38.49%45.44%49.56%43.53%45.06%48.59%42.12%
Gross Profit63.54M68.52M71.81M73.65M31.39M69.58M68.83M37.93M32.68M33.18M35.77M36.72M30.95M40.29M42.55M35.77M38.97M50.02M41.85M49.18M
Gross Margin %99.26%98.57%98.34%100%55.48%98.52%100%58.01%61.13%61.81%58.24%62.97%60.28%61.51%54.56%50.44%56.47%54.94%51.41%57.88%
Gross Profit Growth %102.46%-1.52%4.34%94.19%-3.96%109.71%92.44%3.29%5.59%-17.64%-15.95%2.67%-20.57%-19.46%1.67%-27.27%-2.45%16.57%13.08%37.89%
Operating Expenses55.83M58.92M56.72M57.85M27.33M58.77M57.24M26.66M26.88M26.97M27.16M26.87M29.39M31.01M32.47M32.81M31.17M26.13M23.42M23.89M
OpEx / Revenue %87.21%84.75%77.68%78.55%48.32%83.21%83.16%40.78%50.29%50.23%44.22%46.08%57.24%47.35%41.62%46.28%45.18%28.7%28.76%28.12%
Depreciation & Amortization1.15M3.41M1.01M-1.65M1.65M1.11M1.07M1.19M1.13M1.13M1.02M993K971K934K884K908K854K726K557K589K
Combined Ratio %87.95%86.18%79.33%78.55%92.83%84.69%83.16%82.77%89.16%88.43%85.98%83.12%96.96%85.84%87.07%95.84%88.71%73.76%77.35%70.24%
Operating Income7.71M9.61M15.09M15.8M4.05M10.81M11.59M11.27M5.8M6.21M8.61M9.85M1.56M9.27M10.09M2.95M7.79M23.89M18.44M25.29M
Operating Margin %12.05%13.82%20.67%21.45%7.17%15.31%16.84%17.23%10.84%11.57%14.02%16.88%3.04%14.16%12.93%4.16%11.29%26.24%22.65%29.76%
Operating Income Growth %90.35%-11.14%30.23%40.21%-30.08%74.01%34.59%14.43%271.36%-33.01%-14.65%233.42%-79.97%-61.18%-45.28%-88.32%-54.99%11.59%-2.23%41.1%
EBITDA8.87M13.01M16.11M14.14M5.71M11.92M12.66M12.46M6.92M7.35M9.63M10.84M2.53M10.21M10.97M3.86M8.65M24.62M18.99M25.88M
EBITDA Margin %13.85%18.72%22.05%19.2%10.09%16.87%18.39%19.06%12.95%13.69%15.69%18.59%4.93%15.59%14.07%5.45%12.53%27.04%23.33%30.46%
Interest Expense00000000000000000000
Non-Operating Income00000000000000000000
Pretax Income7.71M9.61M15.09M15.8M4.05M10.81M11.59M11.27M5.8M6.21M8.61M9.85M1.56M9.27M10.09M2.95M7.79M23.89M18.44M25.29M
Pretax Margin %12.05%13.82%20.67%21.45%7.17%15.31%16.84%17.23%10.84%11.57%14.02%16.88%3.04%14.16%12.93%4.16%11.29%26.24%22.65%29.76%
Income Tax1.65M2.09M2.88M3.52M882K2.45M2.27M2.4M1.27M377K1.53M2.26M380K1.75M2.17M674K1.61M4.98M3.93M5.51M
Effective Tax Rate %21.36%21.75%19.06%22.28%21.76%22.65%19.62%21.27%21.94%6.07%17.72%22.96%24.34%18.85%21.56%22.82%20.63%20.84%21.34%21.77%
Net Income6.07M7.52M12.21M12.28M3.17M8.36M9.31M8.87M4.53M5.84M7.08M7.58M1.18M7.53M7.91M2.28M6.18M18.91M14.5M19.78M
Net Margin %9.48%10.81%16.73%16.67%5.61%11.84%13.53%13.57%8.46%10.87%11.54%13.01%2.3%11.49%10.15%3.21%8.96%20.77%17.81%23.28%
Net Income Growth %91.33%-10.11%31.12%38.41%-29.92%43.28%31.49%16.95%283.15%-22.46%-10.48%232.82%-80.91%-60.21%-45.44%-88.48%-55.26%13.69%-5.22%36.47%
EPS (Diluted)3.203.976.436.491.674.424.924.702.403.093.754.000.623.974.171.203.259.947.6310.42
EPS Growth %91.62%-10.18%30.69%38.09%-30.42%43.04%31.2%17.5%287.1%-22.17%-10.07%233.33%-80.92%-60.06%-45.35%-88.48%-55.42%13.34%-5.45%36.21%
EPS (Basic)3.213.986.476.511.684.444.944.712.403.093.754.000.623.974.171.203.269.987.6610.44
Diluted Shares Outstanding1.89M1.9M1.9M1.89M1.9M1.9M1.89M1.89M1.89M1.89M1.89M1.9M1.9M1.9M1.9M1.9M1.9M1.9M1.9M1.9M